Ronald Kirk Huntsman - Sep 21, 2021 Form 4 Insider Report for Vivos Therapeutics, Inc. (VVOS)

Role
Chief Executive Officer, Director
Signature
/s/ Brad Amman as attorney-in-fact for R. Kirk Huntsman
Stock symbol
VVOS
Transactions as of
Sep 21, 2021
Transactions value $
$21,550
Form type
4
Date filed
9/22/2021, 03:09 PM
Previous filing
Aug 18, 2021
Next filing
Feb 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VVOS Common Stock Purchase $21.6K +5K +47.62% $4.31* 15.5K Sep 21, 2021 Direct
holding VVOS Common Stock 1.74M Sep 21, 2021 See footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VVOS Stock Option (Right to Buy) 333K Sep 21, 2021 Common Stock 333K $1.65 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
F2 The option provides for vesting in five equal annual installments beginning on January 15, 2017.